Apart from Deerfield, Justin John Ferayorni 's Tamarack Capital Management is also bullish on Endologix, Inc. (NASDAQ:ELGX). In the second quarter of 2014, it increased its stake in the company by 67% to 2.38 million shares. Endologix, Inc. (NASDAQ:ELGX) also features as a prominent pick of Donald Chiboucis ' Columbus Circle Investors, which as of June 30, 2014 owns 1.35 million shares. Endologix, Inc. (NASDAQ:ELGX) is a $760 million market cap company that manufactures minimally invasive treatments for aortic disorders. The company expects global revenues for the fiscal year 2014 of in the range of $145 million to $148 million, which represents a growth of 10% to 12% over the revenues it reported for 2013. It also expects the net loss per share to be in the range of $0.37 to $0.43. Most analysts and brokerages are positive on the stock with average recommendation being 'Overweight' and average target price amounting to $15.17 per share.